Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2026-05-27 @ 7:13 PM
Study NCT ID:
NCT04876456
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-26
First Post:
2021-05-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Trial of Cabozantinib With Patients With Refractory GCTs
Sponsor:
Jennifer King
Organization: